Skip to main navigation
Skip to search
Skip to main content
Sort by
Medicine and Dentistry
Aneuploidy
89%
Cell-Free DNA
70%
Circulating Tumor DNA
59%
Circulating Tumor Cell
51%
Breast Cancer
50%
Neoplasm
37%
Screening Test
32%
Lymph Node
31%
Prostate Cancer
31%
Liquid Biopsy
26%
Metastatic Carcinoma
22%
Colorectal Liver Metastasis
20%
Estrogen Receptor
19%
DNA Determination
17%
Primary Tumor
17%
Castration Resistant Prostate Cancer
16%
Cerebrospinal Fluid
15%
Urothelial Cancer
15%
Liver Metastasis
15%
Metastatic Colorectal Cancer
15%
DNA Methylation
15%
Methylation
15%
DNA Sequence
15%
Pembrolizumab
15%
Metastatic Breast Cancer
15%
Colon Carcinoma
15%
Retrospective Study
15%
Proliferating Cell Nuclear Antigen
15%
Biomarker Study
15%
CDK4/6 Inhibitor
15%
Hazard Ratio
15%
Cell Count
14%
Proportional Hazards Model
12%
Next Generation Sequencing
12%
Disease Free Survival
10%
Microsatellite Instability
10%
Recurrence Free Survival
9%
Blood Donor
9%
Diseases
8%
Cytotechnology
7%
Exon
7%
Tumor
7%
Gene Frequency
7%
Overall Survival
6%
Biological Marker
6%
Sanger Sequencing
5%
Cancer Staging
5%
Tumor Progression
5%
Tumor Localization
5%
Colon Tumor
5%
Biochemistry, Genetics and Molecular Biology
Circulating Tumor DNA
100%
Aneuploidy
94%
DNA Methylation
62%
Methylation
59%
DNA Analysis
45%
Screening Test
43%
DNA Sequence
35%
Next Generation Sequencing
35%
Blood Plasma
23%
Estrogen Receptor
17%
Quantitative Reverse Transcription Polymerase Chain Reaction
16%
Germline
15%
FABP1
15%
IGFBP3
15%
Cell Adhesion
15%
Prospective Study
15%
Germ Cell
15%
Mesenchymal-Epithelial Transition
15%
Pembrolizumab
15%
Primary Cell
15%
Exon
15%
RNA
15%
Biomarker Study
15%
DNA Profiling
15%
Differentially Methylated Regions
12%
Gene Frequency
11%
Cell Count
10%
Recurrence Free Survival
9%
Genomics
8%
Aromatase Inhibitor
7%
Phosphatidylinositol-4,5-bisphosphate 3-Kinase
7%
Alpha Chain
7%
Enzyme Active Site
7%
Wild Type
7%
Whole Genome Sequencing
7%
Epigenetics
6%
Alpha 1-Antitrypsin
5%
CpG Island
5%
Pharmacology, Toxicology and Pharmaceutical Science
Aneuploidy
71%
Neoplasm
63%
Circulating Tumor DNA
56%
Breast Cancer
31%
Prostate Cancer
31%
Estrogen Receptor
19%
Malignant Neoplasm
17%
Primary Tumor
17%
Metastatic Breast Cancer
15%
Cyclin E
15%
Pembrolizumab
15%
Cycline
15%
Colorectal Liver Metastasis
15%
Liver Metastasis
15%
Metastatic Colorectal Cancer
15%
Retrospective Study
15%
Biomarker Study
15%
Castration Resistant Prostate Cancer
15%
Recurrence Free Survival
9%
Taxane
7%